Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test

This study aimed to evaluate the diagnostic value of endoscopic ultrasound (EUS) after neoadjuvant therapy (NT) for gastric cancer restaging by meta-analysis. We conducted a systematic search of studies published on PubMed and Web of Science up to 30th August 2021. Assessing the risk of bias in the...

Full description

Bibliographic Details
Main Authors: Victor Mihai Sacerdotianu, Bogdan Silviu Ungureanu, Sevastita Iordache, Adina Turcu-Stiolica, Antonio Facciorusso, Stefano Francesco Crinò, Adrian Saftoiu
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/1/100
_version_ 1827665995396808704
author Victor Mihai Sacerdotianu
Bogdan Silviu Ungureanu
Sevastita Iordache
Adina Turcu-Stiolica
Antonio Facciorusso
Stefano Francesco Crinò
Adrian Saftoiu
author_facet Victor Mihai Sacerdotianu
Bogdan Silviu Ungureanu
Sevastita Iordache
Adina Turcu-Stiolica
Antonio Facciorusso
Stefano Francesco Crinò
Adrian Saftoiu
author_sort Victor Mihai Sacerdotianu
collection DOAJ
description This study aimed to evaluate the diagnostic value of endoscopic ultrasound (EUS) after neoadjuvant therapy (NT) for gastric cancer restaging by meta-analysis. We conducted a systematic search of studies published on PubMed and Web of Science up to 30th August 2021. Assessing the risk of bias in the included studies was done with the QUADAS-2 tool. We used R and Review Manager 5.4.1 for calculations and statistical analysis. To evaluate the diagnostic value of EUS after NT for gastric cancer restaging, we performed a meta-analysis on six studies, with a total of 283 patients, including true-positive, true-negative, false-positive, and false-negative results for T1-T4, N0. EUS as a diagnostic test for GC patients after chemotherapy has a relatively low DOR for the T2 (3.96) and T4 stages (4.79) and a relatively high partial AUC for the T2 (0.85) and T4 (0.71) stages. Our results reveal that the pooled sensitivity for T stages after chemotherapy is rather low (29–56%), except for the T3 stage (71%). A potential limitation of our study was the small number of included studies, but no significant heterogeneity was found between them. Our meta-analysis concludes that EUS is not recommended or is still under debate for GC restaging after NT.
first_indexed 2024-03-10T01:38:46Z
format Article
id doaj.art-bda188d141d44cef9fc892d90fa2318b
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T01:38:46Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-bda188d141d44cef9fc892d90fa2318b2023-11-23T13:28:13ZengMDPI AGDiagnostics2075-44182022-01-0112110010.3390/diagnostics12010100Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic TestVictor Mihai Sacerdotianu0Bogdan Silviu Ungureanu1Sevastita Iordache2Adina Turcu-Stiolica3Antonio Facciorusso4Stefano Francesco Crinò5Adrian Saftoiu6Gastroenterology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaGastroenterology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaGastroenterology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaPharmacoeconomics Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaPancreas Center, Gastroenterology Unit, Department of Medicine, University of Verona, 37134 Verona, ItalyPancreas Center, Gastroenterology Unit, Department of Medicine, University of Verona, 37134 Verona, ItalyGastroenterology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaThis study aimed to evaluate the diagnostic value of endoscopic ultrasound (EUS) after neoadjuvant therapy (NT) for gastric cancer restaging by meta-analysis. We conducted a systematic search of studies published on PubMed and Web of Science up to 30th August 2021. Assessing the risk of bias in the included studies was done with the QUADAS-2 tool. We used R and Review Manager 5.4.1 for calculations and statistical analysis. To evaluate the diagnostic value of EUS after NT for gastric cancer restaging, we performed a meta-analysis on six studies, with a total of 283 patients, including true-positive, true-negative, false-positive, and false-negative results for T1-T4, N0. EUS as a diagnostic test for GC patients after chemotherapy has a relatively low DOR for the T2 (3.96) and T4 stages (4.79) and a relatively high partial AUC for the T2 (0.85) and T4 (0.71) stages. Our results reveal that the pooled sensitivity for T stages after chemotherapy is rather low (29–56%), except for the T3 stage (71%). A potential limitation of our study was the small number of included studies, but no significant heterogeneity was found between them. Our meta-analysis concludes that EUS is not recommended or is still under debate for GC restaging after NT.https://www.mdpi.com/2075-4418/12/1/100endoscopic ultrasoundgastric cancerrestaging
spellingShingle Victor Mihai Sacerdotianu
Bogdan Silviu Ungureanu
Sevastita Iordache
Adina Turcu-Stiolica
Antonio Facciorusso
Stefano Francesco Crinò
Adrian Saftoiu
Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test
Diagnostics
endoscopic ultrasound
gastric cancer
restaging
title Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test
title_full Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test
title_fullStr Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test
title_full_unstemmed Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test
title_short Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test
title_sort diagnostic value of endoscopic ultrasound after neoadjuvant chemotherapy for gastric cancer restaging a meta analysis of diagnostic test
topic endoscopic ultrasound
gastric cancer
restaging
url https://www.mdpi.com/2075-4418/12/1/100
work_keys_str_mv AT victormihaisacerdotianu diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest
AT bogdansilviuungureanu diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest
AT sevastitaiordache diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest
AT adinaturcustiolica diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest
AT antoniofacciorusso diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest
AT stefanofrancescocrino diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest
AT adriansaftoiu diagnosticvalueofendoscopicultrasoundafterneoadjuvantchemotherapyforgastriccancerrestagingametaanalysisofdiagnostictest